Long-term cost-effectiveness analysis of tirzepatide versus semaglutide 1.0 mg for the management of type 2 diabetes in the United States.
Diabetes, obesity & metabolism（2023）
关键词
United States,cost-effectiveness,modelling,semaglutide,tirzepatide
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要